The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
Aged
Aged, 80 and over
Cardiac Resynchronization Therapy
/ adverse effects
Cardiac Resynchronization Therapy Devices
/ trends
Comorbidity
Europe
Female
Health Care Surveys
Healthcare Disparities
/ trends
Heart Failure
/ diagnosis
Humans
Male
Middle Aged
Patient Selection
Practice Patterns, Physicians'
/ trends
Recovery of Function
Stroke Volume
Time Factors
Treatment Outcome
Ventricular Function, Left
Cardiac resynchronization therapy
Europe population
French population
Heart failure
Insuffisance cardiaque
Population européennes
Population française
Registre
Survey
Journal
Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
06
06
2019
revised:
31
07
2019
accepted:
09
09
2019
pubmed:
11
11
2019
medline:
5
3
2020
entrez:
11
11
2019
Statut:
ppublish
Résumé
The first European Cardiac Resynchronization Therapy (CRT) Survey, conducted in 2008-2009, showed considerable variations in guideline adherence and implantation practice. A second prospective survey (CRT Survey II) was then performed to describe contemporary clinical practice regarding CRT among 42 European countries. To compare the characteristics of French CRT recipients with the overall European population of CRT Survey II. Demographic and procedural data from French centres recruiting all consecutive patients undergoing either de novo CRT implantation or an upgrade to a CRT system were collected and compared with data from the European population. A total of 11,088 patients were enrolled in CRT Survey II, 754 of whom were recruited in France. French patients were older (44.7% aged≥75 years vs 31.1% in the European group), had less severe heart failure symptoms, a higher baseline left ventricular ejection fraction and fewer co-morbidities. Additionally, French patients had a shorter intrinsic QRS duration (19.1% had a QRS<130ms vs 12.3% in the European cohort). Successful implantation rates were similar, but procedural and fluoroscopy times were shorter in France. French patients were more likely to receive a CRT pacemaker than European patients overall. Of note, antibiotic prophylaxis was reported to be administered less frequently in France, and a higher rate of early device-related infection was observed. Importantly, French patients were less likely to receive optimal drugs for treating heart failure at hospital discharge. This study highlights contemporary clinical practice in France, and describes substantial differences in patient selection, implantation procedure and outcomes compared with the other European countries participating in CRT Survey II.
Sections du résumé
BACKGROUND
BACKGROUND
The first European Cardiac Resynchronization Therapy (CRT) Survey, conducted in 2008-2009, showed considerable variations in guideline adherence and implantation practice. A second prospective survey (CRT Survey II) was then performed to describe contemporary clinical practice regarding CRT among 42 European countries.
AIM
OBJECTIVE
To compare the characteristics of French CRT recipients with the overall European population of CRT Survey II.
METHODS
METHODS
Demographic and procedural data from French centres recruiting all consecutive patients undergoing either de novo CRT implantation or an upgrade to a CRT system were collected and compared with data from the European population.
RESULTS
RESULTS
A total of 11,088 patients were enrolled in CRT Survey II, 754 of whom were recruited in France. French patients were older (44.7% aged≥75 years vs 31.1% in the European group), had less severe heart failure symptoms, a higher baseline left ventricular ejection fraction and fewer co-morbidities. Additionally, French patients had a shorter intrinsic QRS duration (19.1% had a QRS<130ms vs 12.3% in the European cohort). Successful implantation rates were similar, but procedural and fluoroscopy times were shorter in France. French patients were more likely to receive a CRT pacemaker than European patients overall. Of note, antibiotic prophylaxis was reported to be administered less frequently in France, and a higher rate of early device-related infection was observed. Importantly, French patients were less likely to receive optimal drugs for treating heart failure at hospital discharge.
CONCLUSION
CONCLUSIONS
This study highlights contemporary clinical practice in France, and describes substantial differences in patient selection, implantation procedure and outcomes compared with the other European countries participating in CRT Survey II.
Identifiants
pubmed: 31706879
pii: S1875-2136(19)30171-8
doi: 10.1016/j.acvd.2019.09.005
pii:
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
713-722Informations de copyright
Copyright © 2019. Published by Elsevier Masson SAS.